Evidence map›Paper›PMID 42054286›Full record

ArticleLangmuir : the ACS journal of surfaces and colloids2026

A Bio-Hybrid ZnO Nanoplatform Functionalized with Antimicrobial Peptide/Protein Enhances Multimodal Bacterial Eradication and Accelerated Wound Healing.

Pallavi Samal, Siddharth Satpathy, Vishal Singh, Shyamalendu Tripathy, Manoranjan Arakha

Abstract read
In one paragraph

Article in Langmuir : the ACS journal of surfaces and colloids, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pallavi SamalCentre for Biotechnology, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar 751003, Odisha, India.
Siddharth SatpathyCentre for Biotechnology, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar 751003, Odisha, India.
Vishal SinghCentre for Biotechnology, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar 751003, Odisha, India.
Shyamalendu TripathySchool of Pharmacy, Parul University, Vadodara 391760, Gujarat, India.
Manoranjan ArakhaCentre for Biotechnology, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar 751003, Odisha, India.ORCID 0000-0002-2360-737X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing prevalence of bacterial infections, along with the persistence of biofilms and impaired wound healing, underscores the urgent need for advanced antimicrobial strategies. In the current study, ZnO nanoparticles (NPs) were synthesized by the sol-gel method and functionalized with PEG to improve the colloidal stability and biocompatibility. The PEG-functionalized ZnO NPs were then conjugated with the antimicrobial peptide nisin and the enzyme lysozyme to obtain two distinct nanoconjugates: nisin-PEG-ZnO and lysozyme-PEG-ZnO. Extensive physicochemical analyses, including Fourier-transform infrared (FT-IR), ultraviolet-visible (UV-vis) spectroscopy, X-ray diffraction (XRD), scanning electron microscopy (SEM), energy dispersive spectroscopy (EDS), ζ-potential, dynamic light scattering (DLS), and thermogravimetric analysis (TGA), validated the successful synthesis of ZnO NPs and their efficient PEG-mediated surface functionalization. The antimicrobial potential of nanoconjugates against

Indexed as

Anti-Bacterial AgentsAntimicrobial PeptidesMuramidaseNanoparticlesNisinWound HealingZinc OxideAnimalsBiofilmsEscherichia coliMicrobial Sensitivity TestsPolyethylene GlycolsRatsStaphylococcus epidermidisAnti-Bacterial AgentsAntimicrobial PeptidesMuramidaseNisinPolyethylene GlycolsZinc Oxide

Identifiers

PMID42054286
PMCPMC13178075

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.